Physician profile
Robert A Thompson
NPI 1043248206
$7,644.00
in general payments reported to CMS, 2019-2025
58 companies · $2,632 in 2025
The $2,632 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $486 · 2021: $507 · 2022: $977 · 2023: $1,020 · 2024: $1,367 · 2025: $2,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,544 · Travel and Lodging: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,543.55 |
| Travel and Lodging | $1,474.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,746.19 | 2019-2025 | Solyx Sis System, Ams 700, Rezum Generator |
| Teleflex LLC | $575.02 | 2022-2025 | Urolift, Barrigel |
| Axonics, INC. | $565.12 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $389.48 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $388.82 | 2019-2024 | Myrbetriq, Xtandi |
| Abbvie INC. | $374.75 | 2020-2025 | Botox |
| Coloplast Corp | $302.28 | 2019-2025 | Altis |
| Olympus America INC. | $274.39 | 2019-2025 | Itind System, Uropass |
| Urogen Pharma, INC. | $189.61 | 2023-2025 | Jelmyto |
| Endo USA, INC. | $168.75 | 2024-2025 | Aveed, Xiaflex |
| Urovant Sciences INC | $166.23 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $166.14 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $165.39 | 2019-2025 | Adstiladrin |
| Tolmar, INC. | $153.58 | 2023-2025 | Eligard, Jatenzo |
| Acerus Pharmaceuticals Corporation | $140.16 | 2020-2022 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.